An early-stage healthcare technology venture capital investment firm based in Boston, Massachusetts recently raised $200 million for its first dedicated healthcare technology-focused fund in 2015. The firm primarily invests in companies in the seed, series A and B stages targeting healthcare technology and services and is seeking 8-10 new investments within the next year. The firm typically invests an initial range of $500K-$5M and may go up to investing $10M-$15M per company overall, though the size may vary depending on the opportunity. The firm primarily invests in companies based in the US, though is open to companies on a global level. The firm seeks to be a significant investor in any of its portfolio companies and will often serve on the boards of those companies.
In the healthcare technology sector, the firm is actively seeking new investments in healthcare software and services sectors with a specific focus on healthcare analytics, healthcare infrastructure, and novel service delivery models. The firm has a specific interest in transformational technologies and services that enable value-based healthcare and leverage wireless, data and analytics technologies. The firm currently is not focused on therapeutics or medical device investment opportunities, though has interest in medical devices with a software/data component, such as sensors. The firm may be open to 510K devices, however, it is not interested in PMA devices. The firm is indication agnostic and invests only in pre-revenue early stage products.
The firm seeks to invest in privately held companies with a strong and experience management team. The group prefers to invest in companies with cutting-edge technologies and large market potential.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org